WCA
SLDB icon

Windsor Creek Advisors’s Solid Biosciences SLDB Stock Holding History

Windsor Creek Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,000
Closed -$55K – 167
2021
Q2 		$55K Buy
+1,000
New +$66.1K 0.01% 167

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Windsor Creek Advisors's SLDB Position: Q3 2021 in Review

Windsor Creek Advisors sold out of Solid Biosciences (SLDB) in Q3 2021, closing a stake of 1,000 shares — an estimated $55K sold.

Windsor Creek Advisors first reported a position in SLDB in Q2 2021 and held it in 1 quarter. The position peaked at $55K in Q2 2021. 91 funds tracked by Wall St. Rank hold SLDB as of Q3 2021.

  • Windsor Creek Advisors reported no remaining Solid Biosciences position as of Q3 2021 after selling out during the quarter.
  • Windsor Creek Advisors sold 1,000 Solid Biosciences shares in Q3 2021, an estimated $55K.
  • Windsor Creek Advisors first reported a position in Solid Biosciences in Q2 2021 and held it in 1 quarter.
  • Windsor Creek Advisors's Solid Biosciences position peaked at $55K in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2021.

Based on Windsor Creek Advisors's 13F filing for Q3 2021, filed 3 Nov 2021.